Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2,185.17
2,320.70
2,383.45
2,597.91
1,873.21
2,178.13
2,437.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,185.17
2,320.70
2,383.45
2,597.91
1,873.21
2,178.13
2,437.30
Raw Material Cost
1,848.08
1,964.20
1,914.99
2,153.45
1,426.82
1,795.99
1,917.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.00
7.99
11.33
11.70
12.57
11.15
9.34
Selling and Distribution Expenses
177.59
188.97
180.95
169.62
205.33
190.61
215.02
Other Expenses
6.95
9.38
8.37
10.08
7.04
6.91
9.99
Total Expenditure (Excl Depreciation)
2,110.13
2,254.98
2,190.94
2,435.55
1,715.08
2,066.85
2,241.49
Operating Profit (PBDIT) excl Other Income
75
65.7
192.5
162.39999999999998
158.1
111.30000000000001
195.79999999999998
Other Income
10.98
5.69
21.49
21.84
28.39
14.59
30.76
Operating Profit (PBDIT)
241.35
222.22
294.62
316.18
315.11
261.03
298.99
Interest
15.00
7.99
11.33
11.70
12.57
11.15
9.34
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
337.10
356.50
468.46
444.46
446.39
382.14
520.07
Depreciation
168.72
168.07
152.49
151.11
150.28
151.21
144.52
Profit Before Tax
57.64
46.16
130.79
153.37
152.26
98.66
145.14
Tax
14.84
7.35
5.73
28.92
10.24
7.48
7.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.93
35.47
120.48
119.85
136.20
85.61
133.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.93
35.47
120.48
119.85
136.20
85.61
133.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.28
3.58
4.17
3.79
5.75
4.36
4.29
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
43.21
39.05
124.65
123.64
141.96
89.97
137.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.11
1.09
1.1
1.07
1.06
1.11
1.07
Reserves
5,801.58
5,627.84
5,616.49
5,531.32
5,312.11
5,393.12
5,108.26
Earnings per share (EPS)
0.05
0.05
0.17
0.17
0.2
0.13
0.19
Diluted Earnings per share
0.05
0.05
0.17
0.17
0.2
0.13
0.19
Operating Profit Margin (Excl OI)
2.82%
2.09%
5.06%
5.51%
7.28%
4.37%
5.08%
Gross Profit Margin
10.36%
9.23%
11.89%
11.72%
16.15%
11.47%
11.88%
PAT Margin
1.69%
1.53%
5.05%
4.61%
7.27%
3.93%
5.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -5.84% vs -2.63% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 10.49% vs -68.62% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 6.42% vs -20.73% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 87.50% vs -29.20% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Shandong Xinhua Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
2,185.17
0
2,185.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,185.17
0
2,185.17
Raw Material Cost
1,848.08
0
1,848.08
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.00
0
15.00
Selling and Distribution Expenses
177.59
0
177.59
Other Expenses
6.95
0.00
6.95
Total Expenditure (Excl Depreciation)
2,110.13
0
2,110.13
Operating Profit (PBDIT) excl Other Income
75.05
0.00
75.05
Other Income
10.98
0
10.98
Operating Profit (PBDIT)
241.35
0
241.35
Interest
15.00
0
15.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
337.10
0
337.10
Depreciation
168.72
0
168.72
Profit Before Tax
57.64
0
57.64
Tax
14.84
0
14.84
Provisions and contingencies
0
0
0.00
Profit After Tax
36.93
0
36.93
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
36.93
0
36.93
Share in Profit of Associates
0
0
0.00
Minority Interest
6.28
0
6.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
43.21
0
43.21
Equity Capital
0
0
0.00
Face Value
1.11
0
0.00
Reserves
5,801.58
0
5,801.58
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
2.82%
0%
0.00
2.82%
Gross Profit Margin
10.36%
0%
0.00
10.36%
PAT Margin
1.69%
0%
0.00
1.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 218.52 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -5.84% vs -2.63% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 16.66% vs 9.01% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.32 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 10.49% vs -68.62% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -69.58% vs 24.13% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.04 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 6.42% vs -20.73% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -19.64% vs 21.74% in Dec 2024
Quarterly - Interest
Interest 1.50 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 87.50% vs -29.20% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 19.05% vs 23.53% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.82%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
